Appendix D

Registered Attendees

Scott Allocco

BioMarker Strategies

Eric Assaraf


Erin Balogh

Institute of Medicine

Robert Bast

University of Texas MD Anderson Cancer Center

Jessica Bayh

Applied Policy

Al Benson III

Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Marian Birkeland

National Comprehensive Cancer Network

Mary Bordoni

Personalized Medicine Coalition

Jennifer Bowman

American Clinical Laboratory Association

Pamela Bradley

American Association for Cancer Research

Joel Brill

Predictive Health, LLC

Jeffrey Bush


Khatereh Calleja


Allen Egon Cholakian

IRDF Project Harvard/Columbia

Deborah Collyar

Patient Advocates in Research

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 97
Appendix D Registered Attendees Scott Allocco Mary Bordoni BioMarker Strategies Personalized Medicine Coalition Eric Assaraf Jennifer Bowman WRG American Clinical Laboratory Association Erin Balogh Institute of Medicine Pamela Bradley American Association for Cancer Robert Bast Research University of Texas MD Anderson Cancer Center Joel Brill Predictive Health, LLC Jessica Bayh Applied Policy Jeffrey Bush BD Al Benson III Robert H. Lurie Comprehensive Khatereh Calleja Cancer Center, Northwestern AdvaMed University Allen Egon Cholakian Marian Birkeland IRDF Project Harvard/Columbia National Comprehensive Cancer Network Deborah Collyar Patient Advocates in Research 97

OCR for page 97
98 GENOME-BASED DIAGNOSTICS Jeff Cossman Andrew Freedman USDS, Inc. National Cancer Institute Robin Harper Cowie Gwen Gordon Biodesix, Inc. Personalized Medicine Coalition Claude Desjardins Daniel Grosu Johns Hopkins Bloomberg School Illumina, Inc. of Public Health Valerie Hutchins Patricia Deverka HillCo HEALTH Center for Medical Technology Policy Usman Iqbal Sanofi Vamil Divan Credit Suisse Ram Iyer Inova Health Systems Noel Doheny Epigenomics, Inc. Leila Jamal Kennedy Krieger Institute Sarah Donovan Avalere Elaine Jeter Palmetto GBA Georgia Dunston Howard University Brett Johnson International Cancer Advocacy Tania Dutta Network Center for Medical Technology Policy Roger Klein University of South Florida School Christopher Earl of Medicine Innotrove, LLC Hon-Sum Ko Raith Erickson U.S. Food and Drug Complete Genomics Administration Lloyd Everson Nicole Kuderer The U.S. Oncology Network Duke University Kelly Filipski Hanns Kuttner National Cancer Institute Hudson Institute

OCR for page 97
APPENDIX D 99 Gabriela Lavezzari Lisa McShane Express Scripts National Cancer Institute Debra Leonard Kala Menon Weill Cornell Medical Center Booz Allen Hamilton Rachel Lindor Donna Messner Arizona State University College of Center for Medical Technology Law Policy Tracy Lively Douglas Moeller National Cancer Institute McKesson Health Solutions Gary Lyman Padmaja Mummaneni Duke University School of U.S. Food and Drug Medicine; Duke Cancer Administration Institute Bill Murray Julie Lynch Cepheid U.S. Department of Veterans Affairs David Nelson EPIC Sciences Elizabeth Mansfield U.S. Food and Drug Lee Newcomer Administration United HealthCare Corporation Stephen Marmaras R. Hannes Niedner Biotechnology Industry 5AM Solutions, Inc. Organization Danielle Pambianco Robert McCormack HillCo HEALTH Veridex, LLC David Parkinson Robert McDonough Nodality Aetna Scott Patterson Mary McGrane Amgen, Inc. U.S. Department of Agriculture Edmund Pezalla Aetna

OCR for page 97
100 GENOME-BASED DIAGNOSTICS Kathryn Phillips Beverlyn Settles-Reaves University of California, San Howard University Francisco, Center for Translational and Policy Paul Sheives Research on Personalized Biotechnology Industry Medicine Organization Steve Phurrough Naoko Simonds Center for Medical Technology National Cancer Institute Policy Mary Lou Smith Margaret Piper Research Advocacy Network Technology Evaluation Center, Blue Cross Blue Shield Stuart Spector Association Center for Medical Technology Policy Bruce Quinn Foley Hoag, LLP Merianne Spencer Center for Medical Technology Samantha Roberts Policy Friends of Cancer Research Sylvia Trujillo Jeffrey Roche American Medical Association Centers for Medicare & Medicaid Services Sean Tunis Center for Medical Technology Greg Rossi Policy AstraZeneca UK Jessica Walrath Drew Saelens Friends of Cancer Research Applied Policy Corinne Warren Howard Scher Center for Medical Technology Memorial Sloan-Kettering Cancer Policy Center Richard Wenstrup Richard Schilsky Myriad Genetic Laboratories Comprehensive Cancer Center, University of Chicago Elizabeth West FasterCures Michele Schoonmaker Cepheid

OCR for page 97
APPENDIX D 101 Wendy Wifler Dara Wright Agendia, Inc. Affymetrix Marc Williams Amy Zettle Geisinger Health System Potomac Research Group

OCR for page 97